These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37249720)

  • 1. Applicability of an active matrix metalloproteinase-8 point-of-care test in an oral and maxillofacial surgery clinic: a pilot study.
    Kallio E; Puolakkainen T; Tervahartiala T; Snäll J; Marttila E; Sorsa T; Uittamo J
    Odontology; 2024 Jan; 112(1):250-255. PubMed ID: 37249720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of salivary active matrix metalloproteinase (aMMP)-8 point-of-care test for detecting periodontitis in adults: A systematic review and meta-analysis.
    Wei S; Lin T; Sáenz-Ravello G; Gao H; Zhang Y; Tonetti MS; Deng K
    J Clin Periodontol; 2024 Aug; 51(8):1093-1108. PubMed ID: 38763168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing of aMMP-8 point-of-care test with a modified new disease classification in Finnish adolescent cohorts.
    Heikkinen AM; Raivisto T; Räisänen I; Tervahartiala T; Bostanci N; Sorsa T
    Clin Exp Dent Res; 2022 Oct; 8(5):1142-1148. PubMed ID: 35676762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot Study on the Genetic Background of an Active Matrix Metalloproteinase-8 Test in Finnish Adolescents.
    Heikkinen AM; Raivisto T; Kettunen K; Kovanen L; Haukka J; Pakbaznejad Esmaeili E; Elg J; Gieselmann DR; Rathnayake N; Ruokonen H; Tervahartiala T; Sorsa T
    J Periodontol; 2017 May; 88(5):464-472. PubMed ID: 27989222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral active matrix metalloproteinase-8 immunotest may be less accurate in haemato-oncologic patients.
    Mauramo M; Uutela P; Sorsa T; Tervahartiala T; Bornstein MM; Waltimo T
    Oral Dis; 2024 Mar; 30(2):624-630. PubMed ID: 35925017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot Study on Oral Health Status as Assessed by an Active Matrix Metalloproteinase-8 Chairside Mouthrinse Test in Adolescents.
    Heikkinen AM; Nwhator SO; Rathnayake N; Mäntylä P; Vatanen P; Sorsa T
    J Periodontol; 2016 Jan; 87(1):36-40. PubMed ID: 26430926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of aMMP-8 point-of-care test in indicating periodontal treatment outcomes in stage III/IV periodontitis: A 24-week follow-up study.
    Yilmaz M; Sorsa T; Demir E; Gürsoy M; Suominen A; Tervahartiala T; Räisänen IT; Gürsoy UK
    J Periodontal Res; 2023 Apr; 58(2):325-335. PubMed ID: 36618000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. aMMP-8 Point-of-Care Test (POCT) Identifies Reliably Periodontitis in Patients with Type 2 Diabetes as well as Monitors Treatment Response.
    Heikkinen AM; Sokka TT; Torppa-Saarinen E; Pimiä E; Jokinen M; Maijala M; Rantala I; Tervahartiala T; Sorsa T; Kauppila T
    Diagnostics (Basel); 2023 Jun; 13(13):. PubMed ID: 37443617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point-of-care test of active matrix metalloproteinase-8 predicts triggering receptor expressed on myeloid cells-1 (TREM-1) levels in saliva.
    Räisänen IT; Heikkinen AM; Pakbaznejad Esmaeili E; Tervahartiala T; Pajukanta R; Silbereisen A; Bostanci N; Sorsa T
    J Periodontol; 2020 Jan; 91(1):102-109. PubMed ID: 31343739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active matrix metalloproteinase-8: A potential biomarker of oral systemic link.
    Umeizudike K; Räisänen I; Gupta S; Nwhator S; Grigoriadis A; Sakellari D; Sorsa T
    Clin Exp Dent Res; 2022 Feb; 8(1):359-365. PubMed ID: 34800007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8: agreement between qualitative and quantitative measurements and relation to periodontal inflammation.
    Lorenz K; Keller T; Noack B; Freitag A; Netuschil L; Hoffmann T
    J Periodontal Res; 2017 Apr; 52(2):277-284. PubMed ID: 27214099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.